全面实行医药分开公立医院如何适应 中国医改还有哪些难点

2017-04-13 易利华 健康界

中国医疗市场结构不合理、医药分开对公立医院的挑战、医联体改革与分级诊疗体系的构建,这些都是中国医改的难点所在。

第一个难点:中国医疗市场结构不合理,公立医院过于庞大。

可以说中国医改的供给侧改革任务繁重而艰巨。结合美欧等发达国家的医改,几乎都有一个十年左右的改革期,是用来改革医疗市场结构的,要努力降低公立医院和大医院的比重,让小医院、专科医院、精品医院和民营医院的比重增加。在这个调结构的过程中,无论是对国家和社会,对于病人和医务人员来说,都会带来震荡与阵痛。中国医疗市场中,公立医院要占有几乎80%以上的资源和优势!一方面国家财政负担过重,对于全部公立医院的支付已经难以支撑。另外一个方面,也存在着中国公立医院普遍效能比较偏下,活力与动力不足。全国二万多家公立医院中,究竟需要留下多少家公立医院,这是一个重要的资源配置难题和中国医改选择题与必答题。

第二个难点:中国医改要实行医药分业改革,公立医院如何适应?如何生存?这是一个当前中国医改的现实难题!

有消息说,今年十月前后,中国的公立医院可能几乎全部要实行医药分业,药品零差率的销售方式改革。这对于中国绝大多数的公立医院来说,无疑是一个巨大而又重大的改革难题。长期以来,中国公立医院的生存和发展就依赖于药品的收入和加成,这既减少了各级政府财政的大量支出,客观上又加重了不少病人的负担。对于医院和医生来说,医药分业是一个巨大的业态改变!担心的是补贴的钱从那里来?没有药品加成,医院怎么办?财政投入的增加与医疗收入结构的调整,能否弥补医院取消药品加成后所带来的黑洞?这是一个中国医改有可能带来业态变迁的困难而又影响深远的改革!

第三个难点:中国医改的医联体改革与分级诊疗体系的构建改革,内生动力不足,配套改革也不足。

从目前中国医疗服务体系的建设与发展现状来看,构建打破传统区域和行政分割,实行优势医疗资源共享共建的医疗联合体建设,似乎是一个投入比较少,见效比较快,且对于分级诊疗体系构建比较有利的一种改革举措。但是在现实改革中,还是有许多难点和极易出现偏差的地方。一个是内生动力不足的问题!也就是说,如何让各级医疗机构都得益,都说好,很难做到。另外一个方面,医保政策的支持也是必须的。如果医疗联合体变成了更加封闭割据的医疗小王国!医保只是为了降低自己的支付总额和比例来选择性的评判医疗联合体的优劣,这也是极易走向歧途的问题。医联体和分级诊疗主要还是要看医疗价值、医疗作用、医疗效能的!这是一个中国医改解决许多现实难题的切入点、突破口和抓手!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2011677, encodeId=a0a120116e740, content=<a href='/topic/show?id=97ed21e3449' target=_blank style='color:#2F92EE;'>#中国医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21734, encryptionId=97ed21e3449, topicName=中国医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af60254, createdName=mhm289, createdTime=Mon Sep 04 16:17:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286684, encodeId=6886128668438, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Apr 15 02:17:00 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408890, encodeId=78071408890fe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Apr 15 02:17:00 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534909, encodeId=af6d153490932, content=<a href='/topic/show?id=10123528e63' target=_blank style='color:#2F92EE;'>#医药分开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35287, encryptionId=10123528e63, topicName=医药分开)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=202612558221, createdName=zhishijing, createdTime=Sat Apr 15 02:17:00 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187374, encodeId=924518e3742f, content=mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/48d1fec880a796cc2ad284d7b18e6017.jpg, createdBy=43e51704272, createdName=九天., createdTime=Fri Apr 14 14:12:27 CST 2017, time=2017-04-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2011677, encodeId=a0a120116e740, content=<a href='/topic/show?id=97ed21e3449' target=_blank style='color:#2F92EE;'>#中国医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21734, encryptionId=97ed21e3449, topicName=中国医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af60254, createdName=mhm289, createdTime=Mon Sep 04 16:17:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286684, encodeId=6886128668438, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Apr 15 02:17:00 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408890, encodeId=78071408890fe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Apr 15 02:17:00 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534909, encodeId=af6d153490932, content=<a href='/topic/show?id=10123528e63' target=_blank style='color:#2F92EE;'>#医药分开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35287, encryptionId=10123528e63, topicName=医药分开)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=202612558221, createdName=zhishijing, createdTime=Sat Apr 15 02:17:00 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187374, encodeId=924518e3742f, content=mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/48d1fec880a796cc2ad284d7b18e6017.jpg, createdBy=43e51704272, createdName=九天., createdTime=Fri Apr 14 14:12:27 CST 2017, time=2017-04-14, status=1, ipAttribution=)]
    2017-04-15 tidiq
  3. [GetPortalCommentsPageByObjectIdResponse(id=2011677, encodeId=a0a120116e740, content=<a href='/topic/show?id=97ed21e3449' target=_blank style='color:#2F92EE;'>#中国医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21734, encryptionId=97ed21e3449, topicName=中国医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af60254, createdName=mhm289, createdTime=Mon Sep 04 16:17:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286684, encodeId=6886128668438, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Apr 15 02:17:00 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408890, encodeId=78071408890fe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Apr 15 02:17:00 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534909, encodeId=af6d153490932, content=<a href='/topic/show?id=10123528e63' target=_blank style='color:#2F92EE;'>#医药分开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35287, encryptionId=10123528e63, topicName=医药分开)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=202612558221, createdName=zhishijing, createdTime=Sat Apr 15 02:17:00 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187374, encodeId=924518e3742f, content=mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/48d1fec880a796cc2ad284d7b18e6017.jpg, createdBy=43e51704272, createdName=九天., createdTime=Fri Apr 14 14:12:27 CST 2017, time=2017-04-14, status=1, ipAttribution=)]
    2017-04-15 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=2011677, encodeId=a0a120116e740, content=<a href='/topic/show?id=97ed21e3449' target=_blank style='color:#2F92EE;'>#中国医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21734, encryptionId=97ed21e3449, topicName=中国医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af60254, createdName=mhm289, createdTime=Mon Sep 04 16:17:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286684, encodeId=6886128668438, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Apr 15 02:17:00 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408890, encodeId=78071408890fe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Apr 15 02:17:00 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534909, encodeId=af6d153490932, content=<a href='/topic/show?id=10123528e63' target=_blank style='color:#2F92EE;'>#医药分开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35287, encryptionId=10123528e63, topicName=医药分开)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=202612558221, createdName=zhishijing, createdTime=Sat Apr 15 02:17:00 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187374, encodeId=924518e3742f, content=mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/48d1fec880a796cc2ad284d7b18e6017.jpg, createdBy=43e51704272, createdName=九天., createdTime=Fri Apr 14 14:12:27 CST 2017, time=2017-04-14, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2011677, encodeId=a0a120116e740, content=<a href='/topic/show?id=97ed21e3449' target=_blank style='color:#2F92EE;'>#中国医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21734, encryptionId=97ed21e3449, topicName=中国医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af60254, createdName=mhm289, createdTime=Mon Sep 04 16:17:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286684, encodeId=6886128668438, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Sat Apr 15 02:17:00 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408890, encodeId=78071408890fe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Apr 15 02:17:00 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534909, encodeId=af6d153490932, content=<a href='/topic/show?id=10123528e63' target=_blank style='color:#2F92EE;'>#医药分开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35287, encryptionId=10123528e63, topicName=医药分开)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=202612558221, createdName=zhishijing, createdTime=Sat Apr 15 02:17:00 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187374, encodeId=924518e3742f, content=mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/48d1fec880a796cc2ad284d7b18e6017.jpg, createdBy=43e51704272, createdName=九天., createdTime=Fri Apr 14 14:12:27 CST 2017, time=2017-04-14, status=1, ipAttribution=)]
    2017-04-14 九天.

    mark

    0

相关资讯

驻京十五所军队医院全部参加北京市医药分开综合改革

驻京15所军队医院将于4月8日起,全部参加北京市医药分开综合改革。

北京市3600多家医疗机构正式推行医药分开综合改革

北京市3600多家医疗机构将从今天起正式推行医药分开综合改革。今天0点开始,北京医院的收费系统,将有所调整。

北京医改首日探访:挂号费取消 患者感受价格变化

4月8日是《北京市医药分开综合改革实施方案》正式实施的首日,这一天起,北京3600多家医疗机构全部取消药品加成(不含中药饮片)和挂号费、诊疗费,设立医事服务费,实现补偿机制转换。那么,北京医改首日,就诊的患者能否感受到相关变化呢?8日,记者在北京多家医院进行了探访。北京协和医院门诊楼一楼医改咨询台。汤琪 摄医事服务费怎么收?——医保患者二级医院普通门诊自付2元根据北京市医改新政,公立医疗机构将取消

北京迎接医药分开 各大医院自有“法宝”

4月8日,北京市将启动医药分开改革。根据改革方案,北京将通过取消药品加成、挂号费和诊疗费,设立医事服务费等方式,体现医务人员技术劳务价值,逐步破除以药补医、建立科学合理的补偿机制。作为全国优质医疗资源最丰富的地区,北京的医改备受关注。为了让此项改革顺利实施,北京多家医院积极准备。从信息系统改造到政策宣传,再到应急事件演习,各项举措都在有条不紊地推进,其中不乏亮点。